An interventional study of Exercise and Conventional in Stroke, sponsored by Shifa Tameer-e-Millat University. Active, not recruiting at 1 site in Pakistan. Open to participants aged Up to 55 Years. Per ClinicalTrials.gov, last updated 2026-10-13.
Sponsored by Shifa Tameer-e-Millat University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 333 studies in Stroke with a site in Pakistan — 103 open to participants now, 134 under way, 1 of them phase 3. Stroke · Pakistan.
Among the 333 studies in Stroke with a site in Pakistan, this one is the 132nd largest by planned enrollment of the 306 interventional ones that give a count, is one of 53 that started in 2026, is one of 300 with no phase, reaches primary completion later than 106 of the 133 other live ones, and was the 304th registered.
8,269 studies on the registry are indexed under Stroke; 2,062 are open to participants now.
Browse Stroke studies →103 of the 333 studies in Stroke with a site in Pakistan are open now. Recruiting first, the newest first:
Lahore University of Biological and Applied Sciences · Sites in Pakistan
Ages 45–65
Lahore University of Biological and Applied Sciences · Sites in Pakistan
Ages 45–65
Riphah International University · Sites in Pakistan
Ages 40–60
Ibadat International University, Islamabad · Sites in Pakistan
Ages 40+
Kainat Tariq · Sites in Pakistan
Ages 35–75
A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →
Of the 1,419 Stroke studies recruiting now, 695 (49%) set no upper age limit and 283 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: Up to 55 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
333 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 1 · Phase 3 2 · Phase 4 3
First in 1998; this study’s year is marked. 53 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 46 is close to the median of 48 across 6,037 interventional studies indexed under Stroke.
Median enrollment 42 across the 306 interventional studies, 120 across the 27 observational. Of the 176 that completed or were terminated, 2 (1%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 333 have an industry lead sponsor. The 10 most frequent:
Shifa Tameer-e-Millat University is the lead sponsor of 27 studies on the registry; 10 are open to participants now.
Shifa Tameer-e-Millat University has 7 studies filed under Stroke — fewer than ten, so there is no comparison to draw.
14 of the studies in Stroke with a site in Pakistan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07937111Ibadat International University, IslamabadCOMPARATIVE ANALYSIS OF DUAL-TASK COGNITIVE-MOTOR TRAINING AND ACTION OBSERVATION THERAPY ON UPPER LIMB FUNCTIONAL RECOVERY AND HAND DEXTERITY IN PATIENTS WITH SUBACUTE STROKE | 2026-11-18 |
| NCT07887191Ibadat International University, IslamabadEffectiveness of Epley Maneuver Versus Semont Maneuver on Dizziness and Balance in Stroke Survivors With Posterior Canal BPPV | 2026-11-30 |
| NCT07887360Ibadat International University, IslamabadEffect of Lower Limb Proprioceptive Neuromuscular Facilitation Combined With Core Stability Training Versus Proprioceptive Neuromuscular Facilitation Alone on Balance and Functional Mobility in Chronic Stroke Survivors | 2026-12-25 |
| NCT07902284Lahore University of Biological and Applied SciencesEffects of Mirror Therapy and Motor Imagery on Upper Limb Motor Functions in Middle Cerebral Artery Stroke | 2026-12-30 |
| NCT07902310Lahore University of Biological and Applied SciencesEffects of Contralateral Gravity Eliminated Gluteus Medius and Ipsilateral Quadratus Lumborum Strengthening on Pelvic Alignment, Balance and Functional Mobility on Subacute Stroke Patients | 2026-12-30 |
Add all 14 to your calendar (.ics) → With an account.
Among the 333 studies in Stroke with a site in Pakistan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This RCT will determine the effects of attention focus training which is a comprehensive intervention to improve cognitive outcomes. Attention is one of the major cognitive outcome and problems with attention can deteriorate the quality of life of people suffering from stroke. Intervention will be provided for 4 weeks. Outcomes will be assessed at baseline and after provision of intervention.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The training group will address the four core components of attention: focus, sustained, selective and alternating attention. Additionally, conventional therapy for stroke will be given.
Other: Exercise · Other: Conventional
Conventional therapy for stroke will be given
Other: Conventional
Focused attention (auditory target detection), Sustained attention (letter cancellation), Selective attention (cancellation with distractors), Alternating attention (number-letter switching)
Positioning and bed mobility, sitting balance training, standing training
Stroop Color-Word Test
It consists of three conditions/sheets: (i) Word (W), in which the participant reads color words; (ii) Color (C), in which they name the ink colors; (iii) Color-Word (CW), in which they name the ink color while inhibiting the tendency to read the conflicting word. Responses are recorded and calculated for all three sheets. Scores are based on the number of correct responses within the specified time (45 minutes), with higher scores indicating better performance.
Time frame: Baseline and post 4 weeks of intervention
Trail Making Test Test (A & B)
Trial Making Test (TMT) consists of two parts (TMT-A \& TMT-B). For TMT-A, participants connect numbers in sequential order (e.g. 1-2-3-4). For TMT-B, participants alternate between numbers and letters (e.g. 1-A-2-B-3-C). Participants are instructed to completed each task as quickly and accurately as possible. Score is primarily the time in seconds to complete the task. Lower time denotes better performance.
Time frame: Baseline & post 4 weeks of intervention
Stroke Impact Scale
Stroke Impact Scale (SIS) scores range from 0 to 100 for each domain. A score of 0 indicates greatest impact of stroke or complete inability to perform tasks within that domain, while a score of 100 indicates no disability, no difficulty performing tasks, and the best possible outcome. Higher scores indicate better functioning and less impact of stroke.
Time frame: Baseline and post 4 weeks of intervention
Plan to share: No
No publications or documents are linked to this record.
Ran from Aug 2026 to primary completion in Sep 2026, 1 month.
Of 3,119 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's 1 month is below that.
Counting every sponsor, half of 3,263 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
Start moved once since we started tracking on Sep 25, 2026: Jul 2026 → Aug 2026, on Oct 13, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shifa Tameer-e-Millat University